USPTO trademark

IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

AllowedUSPTOWord markClass 44

"IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES" is a word mark owned by Amicus Therapeutics, Inc., filed at the USPTO on March 31, 2023. It has been allowed and covers class 44 (Medical, Beauty, and Agricultural).

View Amicus Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES trademark as filed
As filed with the USPTO
Status
Allowed
Since April 3, 2026
Filed
March 31, 2023
Registered
Not yet
Expires
Not recorded
Application no.
97867910
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Amicus Therapeutics, Inc.

Philadelphia, United States

57 trademarks in the portfolioView company

Representative

Matthew P. Hintz, Esq.

Lowenstein Sandler LLP

Goods and services

What the mark covers

The products and services IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES is filed for, grouped by Nice class.

  • Providing medical services for the treatment of rare genetic diseases; Providing health information in the field of rare genetic diseases; Providing medical information in the field of rare genetic diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Sou teas extension received
  2. Notice of approval of extension request e-mailed
  3. Sou extension 4 granted
  4. Sou extension 4 filed
  5. Sou teas extension received
  6. Notice of approval of extension request e-mailed
  7. Sou extension 3 granted
  8. Sou extension 3 filed
  9. Sou teas extension received
  10. Notice of approval of extension request e-mailed

10 earlier steps on the official record.

FAQ

About IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

Who owns the trademark "IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES"?

The USPTO trademark "IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES" (application 97867910) is owned by Amicus Therapeutics, Inc.

What is the status of "IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b8b-912d-77fc-88db-b3d9d67082be
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b8b-912d-77fc-88db-b3d9d67082be",
  "object": "trademark",
  "mark_text": "IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97867910",
  "filing_date": "2023-03-31",
  "nice_classes": [
    44
  ],
  "owners": [
    {
      "name": "AMICUS THERAPEUTICS, INC.",
      "entity_id": "ent_019eb705-8543-708f-b2ee-be1e829cc3dd"
    }
  ]
}